Evidence library

Supplement Topic Guides

Find the question closest to yours—from choosing a magnesium form to understanding a research peptide. These guides organize evidence, tradeoffs, safety context, and what remains uncertain.

Forms and formulas

Choose the right version

Use these when the ingredient is familiar but the form, dose, quality markers, or label is not.

Everyday topics

Evaluate popular supplement categories

Evidence-first reviews for categories that attract strong marketing but still require careful product and goal matching.

Goals and routines

Start with the outcome or decision

Use these broader guides to compare options, plan a routine, or identify what should be checked first.

Advanced and harm reduction

Research higher-risk and regulated topics

Educational context for prescription-adjacent compounds, research peptides, withdrawal, and harm reduction—not a purchase or self-treatment list.

BPC-157

Review preclinical evidence, safety uncertainty, and current legal context.

Open guide

CagriSema & Cagrilintide

Track the pending FDA review, peer-reviewed REDEFINE evidence, amylin/GLP-1 mechanism, and federal cagrilintide compounding prohibition.

Open guide

CJC-1295

Understand the mechanism, research evidence, forms, and legal status.

Open guide

GHK-Cu

Separate topical cosmetic evidence from injectable and research-only use.

Open guide

Nutrition and Supplements on GLP-1s

Review protein, hydration, and nutrient issues discussed with GLP-1 medications.

Open guide

Dipping Tobacco Alternatives

Compare replacement paths through a harm-reduction and cardiovascular lens.

Open guide

Ipamorelin

Review mechanism, evidence limits, safety, and current legal context.

Open guide

Kratom 7-OH Withdrawal

Evidence-informed harm reduction, symptom context, and routes to medical support.

Open guide

Methylene Blue as a Nootropic

Separate tiny cognition evidence from MAO-A, serotonin, G6PD, and product-grade safety risks.

Open guide

Orforglipron (Foundayo)

Track the 2026 oral small-molecule GLP-1 approval, pivotal weight-loss evidence, safety label, and maintenance data.

Open guide

Psychedelic-Adjacent Herbs

Traditional and ritual botanicals viewed through a harm-reduction framework.

Open guide

PT-141 (Bremelanotide)

Distinguish the approved indication from off-label and research-only use.

Open guide

Retatrutide

Track the 2026 phase 3 triple-agonist results, investigational status, FDA compounding prohibition, and gray-market risk.

Open guide

Semaglutide

Evidence, mechanism, side effects, and brand-versus-compounded context.

Open guide

TB-500

Review repair research, evidence limits, safety, and legal status.

Open guide

Tirzepatide

Evidence, dual GIP/GLP-1 mechanism, side effects, and prescribing context.

Open guide

Melatonin Dosing

Understand lower-dose evidence, timing, and common reasons for side effects.

Open guide

Editorial reading context

How to read Supplement Topic Guides

Browse evidence-first guides on supplement forms, popular categories, goal-based routines, advanced compounds, and harm reduction. This guide is intended to help readers make sense of evidence, safety, and practical fit without turning supplement research into a one-size-fits-all checklist. Use it alongside the linked herb and compound profiles for deeper mechanism and safety details.

For Supplement Topic Guides, focus on whether the evidence matches the exact outcome you care about, whether the dose discussed is realistic, and whether the safety profile fits your medical context. Strong marketing language should carry less weight than human evidence and transparent product quality.

When a page discusses dependence-forming substances, restricted compounds, or high-risk contexts, treat it as harm-reduction education only. It is not a buying guide, dosing instruction, or substitute for professional care.